SEC Filing Details

SEC Filing Details

Document Details

Form
DEF 14A
Filing Date
Jan 24, 2024
Document Date
Feb 23, 2024
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
ReShape Lifesciences
Issuer
RESHAPE LIFESCIENCES INC.
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE